ISSN: 2476-2024

Diagnostic Pathology: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • Diagn Pathol Open 5: 166,
  • DOI: 10.4172/2476-2024.1000166

Intestinal Epithelial Organoids: A Platform for Discovering Mucosal Healing Drug Candidates for the Treatment of Inflammatory Bowel Diseases

Qin Yan1, Arong Gaowa1, Eiji Kawamoto1,2, Eun Jeong Park1 and Motomu Shimaoka1*
1Department of Molecular Pathobiology and Cell Adhesion Biology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan
2Emergency and Critical Care Center, Mie University Hospital, Tsu, Mie, 514-8507, Japan
*Corresponding Author : Dr. Motomu Shimaoka, Department of Molecular Pathobiology and Cell Adhesion Biology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan, Tel: (+81)-59-231-5036, Fax: (+81)-59-231-5209, Email: motomushimaoka@gmail.com

Received Date: Jul 20, 2020 / Accepted Date: Aug 03, 2020 / Published Date: Aug 10, 2020

Abstract

Inflammatory bowel diseases (IBDs) are chronic, remitting inflammatory disorders of the digestive system. Intestinal epithelial dysfunction constitutes an integral part of the pathogenesis of IBD. Epithelial regeneration is a complex process, and the healing of injured tissue requires the resolution of inflammation followed by the proper and rapid proliferation of epithelial cell groups involving stem cell activation and mobilization. In recent years, an in vitro culture method for intestinal epithelial stem cells has been established. Known as “organoid culture”, this novel culture system regenerates differentiated crypt lineages and reflects the architecture of intestinal mucosa. The mechanisms for controlling the growth and differentiation of intestinal epithelium have been investigated at the molecular level. Furthermore, this approach has been used for studying various intestinal diseases including cancer, based on the fact that functional abnormality of intestinal epithelium contributes to the development of infectious diseases. Therefore, using organoid culture to investigate the mucosal healing of IBD by identifying the molecule that controls the regenerative response induced by intestinal epithelial stem cells may lead to potent therapies for IBD patients.

Keywords: Organoid; Mucosal healing; Stem cell; Inflammatory bowel diseases

Citation: Yan Q, Gaowa A, Kawamoto E, Park EJ, Shimaoka M (2020) Intestinal Epithelial Organoids: A Platform for Discovering Mucosal Healing Drug Candidates for the Treatment of Inflammatory Bowel Diseases. Diagn Pathol Open 5: 166. Doi: 10.4172/2476-2024.1000166

Copyright: © 2020 Yan Q, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top